What is NDC 51655-776?

51655-776 is the product NDC for Benzonatate, Benzonatate 200 mg/1 capsule, listed with the FDA by Northwind Health Company, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

Northwind Health Company, LLC, NDC labeler code 51655. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Benzonatate?

134 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Benzonatate NDC 51655-776 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)51655-776Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51655-0776Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51655-776-52	5165507765251655077652	30 CAPSULE in 1 BOTTLE, PLASTIC (51655-776-52)Marketed from Jul 9, 2021
51655-776-54	5165507765451655077654	15 CAPSULE in 1 BOTTLE, PLASTIC (51655-776-54)Marketed from Apr 7, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Benzonatate
Generic name (nonproprietary): benzonatate
Active ingredients: Benzonatate — 200 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Northwind Health Company, LLCNDC labeler code 51655
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040627
Marketing start: Apr 7, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Tracheobronchial Stretch Receptor Activity (Physiologic effect)
Identifiers: Product ID 51655-776_4ba7befd-4844-5d35-e063-6294a90a1a60SPL ID 4ba7befd-4844-5d35-e063-6294a90a1a60SPL set ID da807eb3-349e-61b9-e053-2995a90a0e21RxCUI 283417UNII 5P4DHS6ENR
Pharmacologic class: Non-narcotic Antitussive

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451655077652 followed by a unit qualifier and the quantity

Package 51655-0776-52. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 1, 2026.

Indications (excerpt from the label)

INDICATIONS & USAGE Benzonatate USP is indicated for the symptomatic relief of cough.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51655-776

What is NDC 51655-776?: 51655-776 is the product NDC for Benzonatate, Benzonatate 200 mg/1 capsule, listed with the FDA by Northwind Health Company, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Benzonatate.
What is the active ingredient?: Benzonatate.
Who is the labeler?: Northwind Health Company, LLC, NDC labeler code 51655. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Benzonatate?: 134 other product NDCs are listed under this name. See all Benzonatate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Benzonatate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Benzonatate	Benzonatate 100 mg/1	CapsuleOral	Strides Pharma Science Limited	64380-712	64380-0712-0664380-0712-07
Benzonatate	Benzonatate 200 mg/1	CapsuleOral	Strides Pharma Science Limited	64380-713	64380-0713-0664380-0713-07
Benzonatate	Benzonatate 150 mg/1	CapsuleOral	Anvi Pharmaceuticals Inc	87519-111	87519-0111-90
Benzonatate	Benzonatate 100 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4558	70518-4558-0070518-4558-0170518-4558-02+1 more
Benzonatate	Benzonatate 100 mg/1	CapsuleOral	Coupler LLC	67046-1629	67046-1629-03
Benzonatate	Benzonatate 200 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4497	70518-4497-0070518-4497-01
Benzonatate	Benzonatate 100 mg/1	CapsuleOral	St. Mary's Medical Park Pharmacy	60760-869	60760-0869-1560760-0869-30
Benzonatate	Benzonatate 100 mg/1	CapsuleOral	Coupler LLC	67046-1484	67046-1484-03
Benzonatate	Benzonatate 200 mg/1	CapsuleOral	Direct_rx	72189-606	72189-0606-2072189-0606-30
Benzonatate	Benzonatate 100 mg/1	Capsule, Liquid filledOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-898	23155-0898-0123155-0898-05

All 135 Benzonatate NDCs

Other NDCs under ANDA 040627

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040627
Product	Strength	Form · route	Labeler	Product NDC
benzonatate	Benzonatate 100 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-1329
Benzonatate	Benzonatate 200 mg/1	CapsuleOral	QPharma, Inc.	42708-082
benzonatate	Benzonatate 100 mg/1	CapsuleOral	Proficient Rx LP	71205-971
Benzonatate	Benzonatate 100 mg/1	CapsuleOral	Ascend Laboratories, LLC	67877-573
Benzonatate	Benzonatate 200 mg/1	CapsuleOral	Ascend Laboratories, LLC	67877-575
Benzonatate	Benzonatate 100 mg/1	CapsuleOral	Coupler LLC	67046-1629
benzonatate	Benzonatate 100 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-0688
benzonatate	Benzonatate 100 mg/1	CapsuleOral	Proficient Rx LP	63187-928